id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-E-0934-0006,FDA,FDA-2014-E-0934,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2016-11-16T05:00:00Z,2016,11,2016-11-16T05:00:00Z,,2016-11-16T18:25:21Z,,0,0,090000648239a1c3
FDA-2014-E-0934-0005,FDA,FDA-2014-E-0934,"Determination of Regulatory Review Period for Purposes of Patent
Extension; SUPERA PERIPHERAL STENT SYSTEM",Notice,Determinations,2016-02-22T05:00:00Z,2016,2,2016-02-22T05:00:00Z,2016-08-23T03:59:59Z,2016-02-22T17:15:10Z,2016-03542,0,0,0900006481e7c034